Bloomberg Anywhere Remote Login Bloomberg Terminal Demo Request


Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.


Financial Products

Enterprise Products


Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000


Industry Products

Media Services

Follow Us

Bloomberg Customers

February 07, 2016 9:20 AM ET


Company Overview of Jennerex Biotherapeutics, Inc.

Company Overview

Jennerex Biotherapeutics, Inc. develops oncolytic products for cancer. Its pipeline includes JX-594 for treating patients with liver and colorectal cancer; JX-929 for treating patients with pancreatic cancer; JX-1395 for treating patients with prostate cancer; and JX-next generation therapeutic classes for treating patients with various other cancers. The company’s products are designed to attack cancer tumors through synergistic and complementary mechanisms of action, such as lysis of cancer cells through viral replication, reduction of the blood supply to tumors through vascular targeting and destruction, and stimulation of the body's immune response against cancer cells. Jennerex Biothera...

450 Sansome Street

16th Floor

San Francisco, CA 94111

United States

Founded in 2003





Key Executives for Jennerex Biotherapeutics, Inc.

Chief Executive Officer, President, and Director
Age: 51
Executive Vice President of Corporate Strategy
Age: 66
Head of Pusan Research Site and Research Advisor
Corporate Counsel and Director
Age: 56
Compensation as of Fiscal Year 2015.

Jennerex Biotherapeutics, Inc. Key Developments

Jennerex Biotherapeutics, Inc. Presents at BIO International Convention, Jun-23-2014

Jennerex Biotherapeutics, Inc. Presents at BIO International Convention, Jun-23-2014 . Venue: San Diego Convention Center, San Diego, California, United States.

Similar Private Companies By Industry

Company Name Region
Bio-Origyn, LLC United States
NxLabs Inc. United States
Mylan Pharmaceuticals Inc. United States
Hemophilia Resources of America, Inc. United States
Nova Factor, Inc. United States

Recent Private Companies Transactions

No transactions available in the past 12 months.

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

Most Searched Private Companies

Company Name Geographic Region
Lawyers Committee for Civil Rights Under Law United States
NYC2012, Inc. United States
Bertelsmann AG Europe
Rush University United States
Citizens Budget Commission United States

Sponsored Financial Commentaries

Sponsored Links

Request Profile Update

Only a company representative may request an update for the company profile. Documentation will be required.

To contact Jennerex Biotherapeutics, Inc., please visit --. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at